CME Group Inc. (NASDAQ:CME) Announces Dividend Increase – $1.15 Per Share

CME Group Inc. (NASDAQ:CMEGet Free Report) declared a quarterly dividend on Thursday, February 8th, RTT News reports. Shareholders of record on Friday, March 8th will be given a dividend of 1.15 per share by the financial services provider on Tuesday, March 26th. This represents a $4.60 annualized dividend and a dividend yield of 2.25%. This is a boost from CME Group’s previous quarterly dividend of $1.10.

CME Group has increased its dividend payment by an average of 9.0% per year over the last three years and has increased its dividend every year for the last 13 years. CME Group has a payout ratio of 45.5% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect CME Group to earn $9.47 per share next year, which means the company should continue to be able to cover its $4.40 annual dividend with an expected future payout ratio of 46.5%.

CME Group Stock Performance

CME Group stock opened at $204.00 on Friday. The company has a market capitalization of $73.44 billion, a PE ratio of 24.34, a P/E/G ratio of 2.37 and a beta of 0.48. The firm has a fifty day simple moving average of $207.29 and a two-hundred day simple moving average of $207.64. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group has a twelve month low of $174.01 and a twelve month high of $223.80.

Insider Activity

In other news, insider Derek Sammann sold 10,681 shares of the stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $220.50, for a total transaction of $2,355,160.50. Following the sale, the insider now owns 1,862 shares in the company, valued at $410,571. The transaction was disclosed in a filing with the SEC, which is available at this link. In related news, Director Bryan T. Durkin sold 5,560 shares of the firm’s stock in a transaction that occurred on Monday, December 11th. The shares were sold at an average price of $216.37, for a total value of $1,203,017.20. Following the sale, the director now owns 62,452 shares in the company, valued at $13,512,739.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Derek Sammann sold 10,681 shares of CME Group stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $220.50, for a total transaction of $2,355,160.50. Following the completion of the sale, the insider now directly owns 1,862 shares of the company’s stock, valued at approximately $410,571. The disclosure for this sale can be found here. Insiders sold 18,103 shares of company stock worth $3,971,672 over the last three months. 0.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On CME Group

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Osaic Holdings Inc. raised its holdings in CME Group by 4.2% in the 2nd quarter. Osaic Holdings Inc. now owns 62,457 shares of the financial services provider’s stock worth $11,571,000 after purchasing an additional 2,493 shares during the period. Orion Portfolio Solutions LLC grew its stake in shares of CME Group by 30.8% during the 2nd quarter. Orion Portfolio Solutions LLC now owns 10,399 shares of the financial services provider’s stock valued at $1,927,000 after acquiring an additional 2,448 shares during the period. Wambolt & Associates LLC raised its stake in CME Group by 12.6% during the 2nd quarter. Wambolt & Associates LLC now owns 1,506 shares of the financial services provider’s stock worth $279,000 after acquiring an additional 168 shares during the period. Quilter Plc lifted its holdings in CME Group by 150.6% during the second quarter. Quilter Plc now owns 2,143 shares of the financial services provider’s stock valued at $397,000 after purchasing an additional 1,288 shares in the last quarter. Finally, PCA Investment Advisory Services Inc. bought a new position in shares of CME Group in the second quarter worth approximately $41,000. Hedge funds and other institutional investors own 85.69% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. The Goldman Sachs Group downgraded shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price on the stock. in a research note on Wednesday, January 3rd. Citigroup boosted their price target on CME Group from $215.00 to $240.00 and gave the company a “buy” rating in a report on Thursday, October 12th. Barclays lowered CME Group from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $244.00 to $222.00 in a research report on Monday, January 8th. Morgan Stanley boosted their price objective on shares of CME Group from $215.00 to $220.00 and gave the company an “equal weight” rating in a research report on Thursday, October 26th. Finally, Rosenblatt Securities reaffirmed a “sell” rating and set a $180.00 target price on shares of CME Group in a research note on Thursday, January 4th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $213.89.

Check Out Our Latest Report on CME

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Dividend History for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.